Prostate specific membrane antigen (PSMA) and Prostate Cancer Staging: is our current conventional staging obsolete?

Abstract

The extent of prostate cancer (PC) with imaging is crucial for therapeutic decision-making, particularly in patients suffering from high-risk localized PC or at risk of extended disease (1). In addition, adequate staging and tailored stratification might lead to a positive impact on the natural evolution of the disease, particularly nodal staging (1-5)